Percutaneous Treatment of Congenital Heart Defects in the Rubinstein-Taybi Syndrome

pp. 337-339

Authors

  • Alejandro Contreras MTSAC Full Member of the Argentine Society of Cardiology. 1 Hospital Privado Centro Médico de Córdoba
  • Ana Masciarelli 1 Hospital Privado Centro Médico de Córdoba
  • Analía Bontempo 2 Hospital Italiano de Rosario
  • Aníbal Gentiletti 2 Hospital Italiano de Rosario
  • Alejandro Peirone MTSAC Full Member of the Argentine Society of Cardiology 1 Hospital Privado Centro Médico de Córdoba

DOI:

https://doi.org/10.7775/rac.es.v81.i4.812

Keywords:

Rubinstein-Taybi syndrome, Congenital heart defect, Coartaction of the aorta, Patent ductus arteriosus, Percutaneous treatment

Abstract

The Rubinstein-Taybi syndrome is a genetic disorder characterized by distinctive facial features, abnormalities in hands and feet, microcephaly and mental retardation. Approximately 30% of subjects with this syndrome have associated congenital heart defects. This presentation describes two cases of patients with Rubinstein-Taybi syndrome associated with congenital heart defects: a 25-year-old patient with juxtaductal native aortic coarctation and an 11-month old infant with a large patent ductus
arteriosus. Both patients underwent successful percutaneous intervention, with favorable long-term outcome.

Published

2026-03-25

Issue

Section

PRESENTACIÓN DE CASOS

Most read articles by the same author(s)

1 2 > >>